CLIP2 as radiation biomarker in papillary thyroid carcinoma

被引:40
|
作者
Selmansberger, M. [1 ]
Feuchtinger, A. [2 ]
Zurnadzhy, L. [3 ]
Michna, A. [1 ]
Kaiser, J. C. [4 ]
Abend, M. [5 ]
Brenner, A. [6 ]
Bogdanova, T. [3 ]
Walch, A. [2 ]
Unger, K. [1 ,7 ]
Zitzelsberger, H. [1 ,7 ]
Hess, J. [1 ,7 ]
机构
[1] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Radiat Cytogenet, D-85764 Neuherberg, Germany
[2] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany
[3] Natl Acad Med Sci Ukraine, Inst Endocrinol & Metab, Kiev, Ukraine
[4] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany
[5] Bundeswehr Inst Radiobiol, Munich, Germany
[6] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[7] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, D-85764 Neuherberg, Germany
关键词
INDUCED GENOMIC INSTABILITY; IONIZING-RADIATION; CHERNOBYL ACCIDENT; CANCER; PROTEIN; REARRANGEMENTS; EXPOSURE; KINESIN; RET/PTC; DYNEIN;
D O I
10.1038/onc.2014.311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A substantial increase in papillary thyroid carcinoma (PTC) among children exposed to the radioiodine fallout has been one of the main consequences of the Chernobyl reactor accident. Recently, the investigation of PTCs from a cohort of young patients exposed to the post-Chernobyl radioiodine fallout at very young age and a matched nonexposed control group revealed a radiation-specific DNA copy number gain on chromosomal band 7q11.23 and the radiation-associated mRNA overexpression of CLIP2. In this study, we investigated the potential role of CLIP2 as a radiation marker to be used for the individual classification of PTCs into CLIP2-positive and - negative cases-a prerequisite for the integration of CLIP2 into epidemiological modelling of the risk of radiation-induced PTC. We were able to validate the radiation-associated CLIP2 overexpression at the protein level by immunohistochemistry (IHC) followed by relative quantification using digital image analysis software (P = 0.0149). Furthermore, we developed a standardized workflow for the determination of CLIP2-positive and - negative cases that combines visual CLIP2 IHC scoring and CLIP2 genomic copy number status. In addition to the discovery cohort (n = 33), two independent validation cohorts of PTCs (n = 115) were investigated. High sensitivity and specificity rates for all three investigated cohorts were obtained, demonstrating robustness of the developed workflow. To analyse the function of CLIP2 in radiation-associated PTC, the CLIP2 gene regulatory network was reconstructed using global mRNA expression data from PTC patient samples. The genes comprising the first neighbourhood of CLIP2 (BAG2, CHST3, KIF3C, NEURL1, PPIL3 and RGS4) suggest the involvement of CLIP2 in the fundamental carcinogenic processes including apoptosis, mitogen-activated protein kinase signalling and genomic instability. In our study, we successfully developed and independently validated a workflow for the typing of PTC clinical samples into CLIP2-positive and CLIP2-negative and provided first insights into the CLIP2 interactome in the context of radiation-associated PTC.
引用
收藏
页码:3917 / 3925
页数:9
相关论文
共 50 条
  • [41] AXIN2 is Associated With Papillary Thyroid Carcinoma
    Liu, Xin
    Li, Shuang
    Lin, Xuejun
    Yan, Kangkang
    Zhao, Longyu
    Yu, Qiong
    Liu, Xiaodong
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (02)
  • [42] A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis
    Zou, Xuan
    Gao, Feng
    Wang, Zhi-Yan
    Zhang, Huo
    Liu, Qing-Xie
    Jiang, Lin
    Zhou, Xin
    Zhu, Wei
    CHINESE MEDICAL JOURNAL, 2020, 133 (21) : 2543 - 2551
  • [43] Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
    Teng, Lianghong
    Deng, Wanglong
    Lu, Junliang
    Zhang, Jing
    Ren, Xinyu
    Duan, Huanli
    Chuai, Shannon
    Duan, Feidie
    Gao, Wei
    Lu, Tao
    Wu, Huanwen
    Liang, Zhiyong
    ONCOTARGET, 2017, 8 (13) : 22023 - 22033
  • [44] A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis
    Zou Xuan
    Gao Feng
    Wang Zhi-Yan
    Zhang Huo
    Liu Qing-Xie
    Jiang Lin
    Zhou Xin
    Zhu Wei
    中华医学杂志英文版, 2020, 133 (21) : 2543 - 2551
  • [45] S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis
    Wang, Ge
    Li, Han-ning
    Cui, Xiao-qing
    Xu, Tao
    Dong, Meng-lu
    Li, Shu-yu
    Li, Xing-rui
    JOURNAL OF CANCER, 2021, 12 (19): : 5760 - 5771
  • [46] Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma
    Zhang, Yanqing
    Xu, Desheng
    Pan, Jiaqi
    Yang, Zhengkai
    Chen, Meijun
    Han, Jun
    Zhang, Sijia
    Sun, Lulu
    Qiao, Hong
    ONCOLOGY LETTERS, 2017, 13 (06) : 4252 - 4266
  • [47] Papillary thyroid carcinoma - An overview
    Al-Brahim, Nabeel
    Asa, Sylvia L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (07) : 1057 - 1062
  • [48] Familial papillary thyroid carcinoma
    Kostoglou-Athanassiou, I
    Georgakopoulou, G
    Christodoulou, I
    Kourkoulou, M
    Tournis, S
    Pappas, A
    Grech, J
    Kaldrymidis, P
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 1031 - 1035
  • [49] Papillary and follicular thyroid carcinoma
    Schlumberger, M.
    ANNALES D ENDOCRINOLOGIE, 2007, 68 (2-3) : 120 - 128
  • [50] OCCULT PAPILLARY CARCINOMA OF THE THYROID
    SCHINDLER, AM
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 112 (10) : 339 - 344